Mutational analysis of detected ctDNA might impact especially in rare malignancies associated with recurrent driver genetic events, such as GIST, whose course of disease and relative management is strictly dependent on KIT or PDGFRA oncogenic activation. This evidence concerns the gene KIT and gastrointestinal stromal tumor.